VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
TELA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
TELATELA Bio, Inc.
$0.82$37M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksTELAQuarterly Cash Flow

TELA Bio, Inc. (TELA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

TELA Bio, Inc. (TELA) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

TELA Cash Flow Statement

Quarterly statement

TELA Cash Flow Statement

TELA Bio, Inc. (TELA) cash flow statement — 9-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-9.38M-11.17M-4.87M-5.72M-7.91M-9.72M-7.53M-8.98M-10.7M-14.38M-11.05M-6.97M-11.26M-11.57M-10.98M-7.65M-11.69M-10.43M-9.59M-6.63M
Operating CF Margin %-48.63%-58.61%-23.34%-27.64%-39.14%-52.51%-42.67%-47.39%-66.48%-86.63%-65.01%-46.29%-77.71%-97.19%-94.5%-68.55%-112.3%-126.72%-114.5%-86.62%
Operating CF Growth %-18.67%-14.86%35.33%36.34%26.1%32.39%31.85%-28.92%5.03%-24.28%-0.62%8.9%3.61%-10.97%-14.55%-15.37%-107.6%-21.49%-34.97%-79.67%
Net Income-11.26M-12.27M-9.04M-8.6M-9.92M-11.26M-9.21M-10.37M-12.6M-5.66M-12.89M-10.96M-10.79M-12.03M-9.98M-10.71M-12.74M-10.86M-8.62M-8.27M
Depreciation & Amortization266K264K225K248K270K267K266K263K249K234K161K218K214K215K207K205K621K154K137K127K
Stock-Based Compensation613K816K812K955K985K1.04M1.09M1.08M1.09M1.1M1.24M1.37M1.29M1.13M1.04M1.03M0901K822K733K
Deferred Taxes060K145K033K52K00000000000000
Other Non-Cash Items585K1.17M1.84M1.15M363K755K1.25M875K474K-6.89M416K242K-2.75M4.38M-146K1.11M2.77M4.29M271K863K
Working Capital Changes417K-1.21M1.15M529K367K-579K-926K-830K90K-3.17M21K2.16M764K-5.26M-2.1M718K-2.34M-4.91M-2.2M-87K
Change in Receivables89K593K932K-107K-533K-402K983K-2.01M497K-234K-1.6M-237K-1.2M-18K-890K-416K-1.03M-85K-657K-34K
Change in Inventory862K-2.16M-275K-838K1.96M-1.35M-616K-811K-115K-1.43M785K-567K924K-3.86M467K-2.55M-482K-3.5M-1.49M-2.43M
Change in Payables-1.01M1.59M-63K652K-2.3M1.85M-154K42K-921K1.51M-1.52M884K00-3.17M2.7M-3.69M011K1.02M
Cash from Investing239K190K192K312K204K138K-190K-122K67K4.7M-193K-134K-157K-115K-1.05M-290K-200K-336K-289K-291K
Capital Expenditures-59K-119K-91K-211K-114K-32K-264K-122K-299K-304K-205K-134K-157K-115K-46K-290K-200K-336K-289K-291K
CapEx % of Revenue0.31%0.62%0.44%1.02%0.56%0.17%1.5%0.64%1.86%1.83%1.21%0.89%1.08%0.97%0.4%2.6%1.92%4.08%3.45%3.8%
Acquisitions0309K283K523K0000000000000000
Investments--------------------
Other Investing298K000318K170K74K0366K5M12K000-1M00000
Cash from Financing-15K-298K25.84M24K-3K-116K42.91M98K-5K56K22K71K46.41M-235K-219K34.57M6.65M-146K174K259K
Debt Issued (Net)0014.03M00000000000006.64M000
Equity Issued (Net)-94K28K11.82M45K-3K61K42.92M-19K-11K-328K-4K-13K-1K-279K-275K34.67M5K-153K00
Dividends Paid00000000000000000000
Share Repurchases-94K000-3K0-11K-19K-11K-328K-4K0-1K-279K000-153K00
Other Financing79K-326K-4K-21K0-177K-11K117K6K384K26K84K46.41M44K56K-106K07K174K259K
Net Change in Cash-9.17M-11.3M21.13M-5.26M-7.86M-9.84M35.37M-9.2M-10.65M-9.59M-11.21M-7.06M35.14M-11.89M-12.21M26.5M-5.29M-10.91M-9.71M-6.66M
Free Cash Flow-9.44M-11.29M-4.96M-5.93M-8.02M-9.76M-7.79M-9.11M-11M-14.69M-11.26M-7.1M-11.42M-11.69M-12.03M-7.94M-11.89M-10.77M-9.88M-6.92M
FCF Margin %-48.93%-59.23%-23.77%-28.66%-39.7%-52.68%-44.17%-48.03%-68.34%-88.47%-66.22%-47.18%-78.8%-98.15%-103.5%-71.14%-114.22%-130.8%-117.95%-90.42%
FCF Growth %-17.72%-15.7%36.36%34.87%27.07%33.57%30.75%-28.2%3.72%-25.66%6.43%10.54%3.91%-8.57%-21.79%-14.71%-110.22%-25.08%-38.29%-85.9%
FCF per Share-0.16-0.20-0.10-0.13-0.18-0.22-0.19-0.37-0.45-0.60-0.46-0.29-0.49-0.61-0.63-0.47-0.82-0.74-0.68-0.48
FCF Conversion (FCF/Net Income)0.83x0.91x0.54x0.66x0.80x0.86x0.82x0.87x0.85x2.54x0.86x0.64x1.04x0.96x1.10x0.71x0.92x0.96x1.11x0.80x
Interest Paid1.84M00001.37M519K1.19M1.18M1.18M1.19M1.18M1.15M1.1M1.02M00733K746K752K
Taxes Paid00000000000000000000